NanoPilot has received funding from the European Union Framework Programme for Research and Innovation Horizon 2020. The objective of this four-year long project is to set-up a pilot plant operating under Good Manufacturing Practice (GMP) for the production of polymer-based nanopharmaceuticals. This pilot plant will accelerate the development of nanomedicine, currently in its infancy within the pharmaceutical sector.
Three different processes will be established for the production of three different nanopharmaceuticals.
State of the art production processes including micro reactors and highly advanced characterization techniques will ensure the quality of the nanodrugs.
Existing laboratories owned by the coordinator, will be adapted and certified within this project to enable the operability of the pilot plant.
During the project Nanopilot’s team will work to achieve different objectives:
NanoPilot will last 48 months. The work plan has been divided in 8 Work Packages including:
The NanoPilot consortium consists of 9 partners from 6 Member States: